...
首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >Unsaturated aldehyde, 4-hydroxynonenal (HNE) alters the structural integrity of HSA with consequences in the immuno-pathology of rheumatoid arthritis
【24h】

Unsaturated aldehyde, 4-hydroxynonenal (HNE) alters the structural integrity of HSA with consequences in the immuno-pathology of rheumatoid arthritis

机译:不饱和醛,4-羟基诺(HNE)改变了HSA的结构完整性,随着类风湿性关节炎的免疫病理学的影响

获取原文
获取原文并翻译 | 示例

摘要

Human serum albumin (HSA) - the most abundant plasma protein plays an important role in the transport of endogenous and exogenous molecules in the body. Its modifications have been implicated in a variety of pathological disorders. We have studied the interaction of HNE with HSA at a molecular level by docking experiment and the results suggest a strong interaction between HNE and HSA. Immunological studies revealed that the circulating auto-antibodies in rheumatoid arthritis (RA) patients have a stronger affinity towards HNE-modified HSA. The HSA isolated from RA patients (RA-HSA) exhibited HNE mediated damage in its secondary and tertiary structure when compared to HSA derived from healthy human subjects (NH-HSA). RA patients presented a significant rise in carbonyls and a considerable decline in free thiol content Preferential binding of experimentally induced anti-HNE-HSA antibodies to RA-HSA over NH-HSA was observed by ELISA. The results suggest HNE induced structural perturbations in HSA with neoepitopes that generate anti-HNE-HSA antibodies in RA. Hence, HNE-HSA may provide lead towards the development of a biomarker for the disease. (C) 2018 Elsevier B.V. All rights reserved.
机译:人血清白蛋白(HSA) - 最丰富的血浆蛋白在体内的内源和外源分子的运输中起重要作用。它的修饰涉及各种病理障碍。通过对接实验,我们研究了HNE在分子水平下与HSA的相互作用,结果表明HNE和HSA之间的强烈相互作用。免疫研究表明,类风湿性关节炎(RA)患者的循环自抗体对HNE改性的HSA具有更强的亲和力。与源自健康人受试者(NH-HSA)的HSA相比,从RA患者分离的HSA(RA-HSA)在其二级和三级结构中表现出HNE介导的损伤。 RA患者呈羰基患者显着升高,通过ELISA观察到通过ELISA观察到通过NH-HSA的RA-HSA对RA-HSA的Ra-HSA抗体的游离硫醇含量优先结合的相当大。结果表明HNE诱导HSA的结构性扰动,其新患者在RA中产生抗HNE-HSA抗体。因此,HNE-HSA可以提供导致疾病的生物标志物的发展。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号